Free
Clinical Science  |   April 1999
Halothane Induces Calcium Release from Human Skinned Masseter Muscle Fibers 
Author Notes
  • (Reyford, Tavernier, Beague) Assistant Professor of Anesthesia, Departement d'Anesthesie-Reanimation I et II.
  • (Krivosic-Horber) Professor of Anesthesia, Departement d'Anesthesie-Reanimation I.
  • (Adnet) Professor of Anesthesia, Service d'Accueil et d'Urgence.
  • (Ferri) Professor of Maxillo-facial Surgery, Hopital R. Salengro, CHU Lille.
  • (Haudecoeur) Professor of Physiology, Laboratoire de Pharmacologie, Faculte de Medecine.
Article Information
Clinical Science
Clinical Science   |   April 1999
Halothane Induces Calcium Release from Human Skinned Masseter Muscle Fibers 
Anesthesiology 4 1999, Vol.90, 1019-1025. doi:
Anesthesiology 4 1999, Vol.90, 1019-1025. doi:
MASSETER muscle rigidity (MMR) is an exaggerated increase in masseter muscle tone in response to halothane, succinylcholine, or both. Although MMR may herald anesthetic-induced malignant hyperthermia crisis, [1,2] it is also a nonspecific sign and can be seen in healthy persons with exposure to halothane followed by succinylcholine administration. [3,4] 
The mechanism by which halothane-succinylcholine anesthesia induces an increase in masseter tone is unknown. Succinylcholine-triggered MMR may be a consequence of membrane depolarization, which activates Ca++release from the sarcoplasmic reticulum (SR). Previously we found a heightened caffeine sensitivity of healthy human masseter muscle fibers. [5] Thus, one possible explanation for the response to halogenated agents also could be an inherent hyperreactivity of the SR to calcium-releasing drugs. [6-9] However, halogenated agents also exert a direct depressive effect on the contractile proteins of type 1 skeletal muscle fibers (slow twitch, fatigue resistant). [10] Halogenated agents thus could simultaneously induce Ca++release from the SR and exert a direct negative inotropic effect. If the net effect on the SR exceeds that on the contractile proteins, the increased myoplasmic Ca++concentration may increase the muscle tone.
The purposes of the current study were (1) to determine the fiber type-specific halothane sensitivities of chemically skinned human masseter muscle fibers and to compare them with those of the vastus lateralis fibers, which are commonly used for in vitro contracture testing;(2) to evaluate the effect of halothane on the Ca++sensitivity and maximal Ca++activated force of the contractile proteins of skinned masseter muscle fibers; and (3) to evaluate the effects of succinylcholine on Ca++regulation by the SR.
Materials and Methods
Skinned Fiber Preparation
With informed consent and institutional approval from the Lille Ethics Committee, small fragments of masseter muscle were obtained from 13 healthy persons (6 female, 7 male; mean age, 25 +/− 9 yr) who were undergoing orthognathic or superficial lobe parotid surgery (no masseter muscle involvement). These persons were otherwise healthy, with normal dental occlusion, without trismus or obvious masseter muscle wasting. Vastus lateralis muscle fragments were obtained from nine healthy patients (4 female, 5 male; mean age, 26 +/− 6 yr) undergoing routine elective orthopedic surgery of the lower limbs. These persons had normal quadriceps development and were not bedridden. Systematic routine histologic and histochemical analyses performed on the muscle segments did not show obvious myopathic modifications, and the fiber type composition was consistent with those reported in the literature for these muscle groups. [5,11-16] 
Chemically skinned single fibers were prepared as previously described by Wood et al. [17] Chemical skinning, using a solution containing a high concentration of EGTA (Sigma Chemical Co., St Louis, MO), renders the muscle fiber sarcolemma freely permeable to external solutes. [18] Small muscle fragments were attached at their extremities to maintain their excised length and immediately placed in a skinning solution at 4 [degree sign]C for 24 h. They were transferred to a preserving solution that was identical to the skinning solution except for the addition of 50% glycerol (Merck, Darmstadt, Germany) and stored at -20 [degree sign]C until use (for 1 or 2 weeks). This technique is identical to that used by some other laboratories. [19,20] 
Single fibers were dissected from the main fascicle and mounted horizontally between two clamps in a muscle bath, as previously described. [5,10] Resting tension was applied by stretching the fiber by 20% of its initial length. The sarcomere length in our procedure was verified using a calibrated micrometer and corresponded to 2.69 +/− 0.14 [micro sign]m. This technique has been validated using the diffraction of a He-Ne laser beam to correspond to a sarcomere length of 2.7 [micro sign]m. [21,22] For all experiments described here, the length of the fibers was kept constant to avoid sarcomere length-dependent changes in Ca++sensitivity. All experiments were performed at room temperature (20 +/− 1 [degree sign]C).
Solutions and Vapor Anesthetics
The calculation and composition of the solutions used have been published previously. [5,23] Halothane and prese0rvative-free succinylcholine were from Zeneca Pharma (Cergy, France) and Sigma Chemical, respectively. All chemicals were reagent grade. To assess effects of halothane, the test solutions were equilibrated by continuous bubbling for 20 min with the anesthetic agent. Halothane was mixed with 100% nitrogen using a calibrated vaporizer (Fluotec Mark III; Cyprane, Keighley, UK). The anesthetic concentrations in the gas phase were monitored using an infrared calibrated analyzer (Capnomac; Datex, Helsinki, Finland). The anesthetic concentrations used were 0.5, 1, 2, 3, and 4 vol% halothane. The anesthetic concentrations obtained in the experimental chamber were measured by gas-liquid chromatography (head space technique), as previously described. [10] Based on the anesthetic concentration displaced into the gas phase, the concentrations calculated to be in the experimental solution after 20 min of continuous bubbling were as follows: 0.28 +/− 0.02 mM, 0.55 +/− 0.05 mM, 1.10 +/− 0.08 mM, 1.65 +/− 0.11 mM, and 2.20 +/− 0.12 mM for 0.5, 1, 2, 3, and 4 vol% halothane (concentrations in the gas phase given by the calibrated analyzer), respectively.
Halothane Sensitivity
The threshold concentration (halothane sensitivity) was defined as the concentration of halothane that first induced a tension greater than 10% of the maximal tension obtained with Ca++16 [micro sign]M (pCa 4.8) solution on the same fiber. The SR of the fiber was loaded with Ca++0.16 [micro sign]M (pCa 6.8) solution, which itself does not induce a contracture. After 30 s of Ca++loading, fibers were rinsed twice with wash solutions to remove excess Ca++and challenged with a test solution equilibrated with a known halothane concentration for 30 s. If no increase in tension was observed at a given halothane concentration, the fiber was exposed to 40 mM caffeine solution (Prolabo, Fonteney S/Bois, France) to release calcium completely from the SR. Between each successive concentration of halothane, fibers were returned to baseline condition by rinsing with the following sequence: relaxing solution, 40 mM caffeine, and relaxing solution to load with Ca++0.16 [micro sign]M solution in the same manner (Figure 1).
Figure 1. The sequence for determining halothane sensitivity in human skinned masseter muscle fibers. After the sarcoplasmic reticulum is loaded with Ca++solution (pCa 6.8; pCa =-log Ca++concentration), the fiber is exposed to a stepwise increase in halothane concentration. No contracture is obtained with 0.5 vol% halothane, but significant contracture (>10% increase in tension) is obtained with 1 vol% halothane (threshold contracture). Hal 0.5, 1, and Caf 40 are 0.5, 1 vol% halothane and 40 mM caffeine solutions, respectively.
Figure 1. The sequence for determining halothane sensitivity in human skinned masseter muscle fibers. After the sarcoplasmic reticulum is loaded with Ca++solution (pCa 6.8; pCa =-log Ca++concentration), the fiber is exposed to a stepwise increase in halothane concentration. No contracture is obtained with 0.5 vol% halothane, but significant contracture (>10% increase in tension) is obtained with 1 vol% halothane (threshold contracture). Hal 0.5, 1, and Caf 40 are 0.5, 1 vol% halothane and 40 mM caffeine solutions, respectively.
Figure 1. The sequence for determining halothane sensitivity in human skinned masseter muscle fibers. After the sarcoplasmic reticulum is loaded with Ca++solution (pCa 6.8; pCa =-log Ca++concentration), the fiber is exposed to a stepwise increase in halothane concentration. No contracture is obtained with 0.5 vol% halothane, but significant contracture (>10% increase in tension) is obtained with 1 vol% halothane (threshold contracture). Hal 0.5, 1, and Caf 40 are 0.5, 1 vol% halothane and 40 mM caffeine solutions, respectively.
×
Effect of Halothane on the Calcium Sensitivity and Maximal Force of the Contractile Proteins of Masseter Muscle Fibers
For this purpose, the fibers were prepared as described before and then were bathed for 20 min in a relaxing solution containing the nonionic detergent Brij 58 (2%)(Sigma Chemical), which irreversibly eliminates the capacity of the SR to sequester Ca++and to release it under appropriate stimulation but does not affect the contractile proteins. [10] A pCa-tension curve was obtained under control conditions by stepwise exposure of the preparation to solutions with increasing Ca++concentrations and measurements of developed tension. Ca++concentrations ranged from pCa 6.8 ([Ca++]= 0.16 [micro sign]M) to pCa 4.8 ([Ca++]= 16 [micro sign]M), where pCa =-log10[Ca++]. Intermediate tensions were expressed as a percentage of the maximal tension. Data were fit using a nonlinear regression analysis (Enzfitter; Elsevier Biosoft, Cambridge, UK). The same fiber was exposed to a stepwise increase in the Ca++concentration equilibrated with 0.75 vol% halothane. A final pCa-tension curve was obtained with calcium solutions free of anesthetic.
In a second series of experiments, changes of tension at maximal Ca++-activatedforce were examined using a pCa 4.8 solution in the presence of 0.75 vol% halothane. Each test was preceded immediately and followed by determination of maximal Ca++-activatedtension with the control solution (i.e., free of anesthetic). [10] Results were expressed as a percentage of these corresponding control values.
Succinylcholine Sensitivity
The following experimental protocols were performed in EGTA-skinned fibers. [17-20] Pure succinylcholine was diluted with wash solution at the following concentrations: 0.1 [micro sign]M, 1 [micro sign]M, 10 [micro sign]M, 100 [micro sign]M, and 10 mM. The SR of the fibers was loaded with Ca++0.16 [micro sign]M solution for 30 s. Fibers were rinsed twice with wash solutions to remove excess Ca++and challenged with increasing concentrations of succinylcholine. If no increase in tension was observed after exposure to increasing concentrations of succinylcholine, the fiber was exposed to 40 mM caffeine solution to completely release calcium from the SR. In a second set of experiments, the effect of succinylcholine on halothane sensitivity was evaluated. After the halothane sensitivity was determined and the fibers returned to baseline values, the fibers were loaded with Ca++0.16 [micro sign]M solution for 30 s and rinsed twice with wash solutions to remove excess Ca++. The fibers were exposed to the maximal concentration of 10 mM succinylcholine for 30 s, and the halothane threshold was determined again. Finally, the fibers were exposed to 40 mM caffeine solution to release calcium completely from the SR.
Muscle Fiber Typing
Fibers were typed by exposure to increasing concentrations of strontium (Sr++; Sigma Chemical), as previously described by Takagi et al. [19] and validated in our laboratory. [5] In the current study and in our previous report, [5] the investigation of type 2 masseter muscle was beyond the limitation of skinned fiber preparation because type 2 fibers were of small diameter and were nonfunctional.
Statistical Analysis
To compare halothane sensitivity, statistical analysis was performed using paired Student t tests within groups of either masseter or vastus lateralis muscles and unpaired Student t tests between muscle groups. Because several type 1 and type 2 muscle fibers were measured in each patient, statistical analysis was performed using paired or unpaired Student t tests, in which the repeated measurements of each type within a patient were first averaged so that a single type 1 and type 2 measurement for that patient could be obtained. The mean difference and standard deviation (SD) of the halothane concentration threshold between the two fiber types in each group of muscle was obtained. For pCa-tension curves in masseter muscle fibers, comparisons of pCa50(the Ca++concentration yielding half-maximal tension) and the Hill coefficient (a measure of the slope of the pCa-tension relation) between control values and 0.75 vol% halothane were made by repeated-measures analysis of variance. Results were expressed as the mean +/− SD. Values of P < 0.05 were considered significant.
Results
The characteristics of 208 skinned fibers (102 masseter muscle fibers obtained from 13 healthy persons, and 106 vastus lateralis fibers obtained from nine healthy persons) were as follows: length of 1,400 +/− 200 [micro sign]m (SD) for masseter muscle, 1,600 +/− 200 [micro sign]m for vastus lateralis fibers; diameter of 66 +/− 16 [micro sign]m for masseter muscle, and 80 +/− 14 [micro sign]m for vastus lateralis fibers.
Halothane Sensitivity
A total of 164 skinned fibers (58 masseter muscle fibers, 106 vastus lateralis fibers) were tested with increasing concentrations of halothane. Figure 1shows a typical trace of the determination of halothane sensitivity for a type 1 masseter muscle fiber. Fifty-eight type 1 (100%) masseter fibers and no type 2 (0%) masseter fibers were studied from nine healthy persons. The mean (+/− SD) halothane threshold for masseter fibers was 0.6 +/− 0.2 vol%. Forty-four type 1 (41%) and 62 type 2 (59%) vastus lateralis fibers were studied from nine healthy persons. There was no significant difference between the mean halothane threshold concentration between type 1 (2.7 +/− 0.6 vol%) and type 2 fibers (2.5 +/− 0.4 vol%) vastus lateralis fibers. The mean (+/− SD) halothane sensitivity for a given muscle differed between masseter and vastus lateralis fibers. Type 1 masseter fibers had significantly lower halothane sensitivities than did either type 1 and type 2 vastus lateralis fibers (P < 0.001;Figure 2).
Figure 2. Halothane sensitivities in human type 1 and 2 skinned masseter and vastus lateralis fibers. The halothane concentration that induced 10% of the maximal contracture with pCa 4.8 solution (pCa =-log Ca++concentration) is shown in panel A for each masseter muscle fiber (circle) and in panel B for each vastus lateralis fiber (square). Closed symbol = type 1 fiber; open symbol = type 2 fiber. There was a significant difference in halothane sensitivity (P < 0.001) between type 1 masseter muscle fiber (0.6 +/− 0.2 vol%) compared with type 1 or type 2 vastus lateralis fibers. There was no significant difference in halothane sensitivity between type 1 (2.7 +/− 0.6 vol%) and type 2 (2.5 +/− 0.4 vol%) vastus lateralis fibers.
Figure 2. Halothane sensitivities in human type 1 and 2 skinned masseter and vastus lateralis fibers. The halothane concentration that induced 10% of the maximal contracture with pCa 4.8 solution (pCa =-log Ca++concentration) is shown in panel A for each masseter muscle fiber (circle) and in panel B for each vastus lateralis fiber (square). Closed symbol = type 1 fiber; open symbol = type 2 fiber. There was a significant difference in halothane sensitivity (P < 0.001) between type 1 masseter muscle fiber (0.6 +/− 0.2 vol%) compared with type 1 or type 2 vastus lateralis fibers. There was no significant difference in halothane sensitivity between type 1 (2.7 +/− 0.6 vol%) and type 2 (2.5 +/− 0.4 vol%) vastus lateralis fibers.
Figure 2. Halothane sensitivities in human type 1 and 2 skinned masseter and vastus lateralis fibers. The halothane concentration that induced 10% of the maximal contracture with pCa 4.8 solution (pCa =-log Ca++concentration) is shown in panel A for each masseter muscle fiber (circle) and in panel B for each vastus lateralis fiber (square). Closed symbol = type 1 fiber; open symbol = type 2 fiber. There was a significant difference in halothane sensitivity (P < 0.001) between type 1 masseter muscle fiber (0.6 +/− 0.2 vol%) compared with type 1 or type 2 vastus lateralis fibers. There was no significant difference in halothane sensitivity between type 1 (2.7 +/− 0.6 vol%) and type 2 (2.5 +/− 0.4 vol%) vastus lateralis fibers.
×
Effect of Halothane on Maximal Force and Calcium Sensitivity of the Contractile Proteins of Masseter Muscle Fibers
The effect of halothane on maximal activated tension was determined in 13 masseter muscle fibers obtained from four patients. Maximally activated tension decreased by 40 +/− 11% in the presence of 0.75 vol% halothane. Figure 3shows a typical example. The force traces were obtained when the preparation was activated maximally at pCa 4.8, initially in the absence of halothane. After a substantial increase in force, the fiber was exposed to halothane, which caused a prolonged and stable decrease in force immediately reversible on switching from halothane-equilibrated solution to control solution of identical pCa.
Figure 3. An example of the changes in maximal activated tension obtained in a skinned masseter muscle fiber during exposure to 0.75 vol% halothane at pCa 4.8 (pCa =-log Ca++concentration). Each exposure to halothane was preceded and followed by determination with the pCa 4.8 control solution alone. Hal 0.75% and R are halothane 0.75 vol% and relaxing solutions, respectively.
Figure 3. An example of the changes in maximal activated tension obtained in a skinned masseter muscle fiber during exposure to 0.75 vol% halothane at pCa 4.8 (pCa =-log Ca++concentration). Each exposure to halothane was preceded and followed by determination with the pCa 4.8 control solution alone. Hal 0.75% and R are halothane 0.75 vol% and relaxing solutions, respectively.
Figure 3. An example of the changes in maximal activated tension obtained in a skinned masseter muscle fiber during exposure to 0.75 vol% halothane at pCa 4.8 (pCa =-log Ca++concentration). Each exposure to halothane was preceded and followed by determination with the pCa 4.8 control solution alone. Hal 0.75% and R are halothane 0.75 vol% and relaxing solutions, respectively.
×
The pCa-tension curves were determined in nine additional masseter muscle fibers obtained from four patients with 0.75 vol% halothane. Tension changes after Ca++changes were plotted and normalized to maximal tension in the same conditions, allowing analysis of the sensitivity of the preparations to Ca++in the absence and in the presence of halothane. Normalized pCa-tension curves were not modified by halothane (Figure 4). Thus, no significant changes were observed for pCa50(6.00 +/− 0.33, 6.02 +/− 0.30, and 6.01 +/− 0.33 for the first control, halothane, and final control, respectively; P = 0.91) or for the Hill coefficient (2.1 +/− 0.9, 1.9 +/− 0.5, and 2.5 +/− 1.2 for the first control, halothane, and final control, respectively; P = 0.08).
Figure 4. Mean pCa-relative tension curves (where pCa=-log Ca++concentration) obtained in control conditions and with 0.75 vol% of halothane in nine type 1 masseter skinned fibers. Neither pCa50(the Ca++concentration for half-maximal tension) nor the slope of the tension-pCa relation was significantly different for halothane and control conditions. The control curve represents the mean of the initial and final control conditions.
Figure 4. Mean pCa-relative tension curves (where pCa=-log Ca++concentration) obtained in control conditions and with 0.75 vol% of halothane in nine type 1 masseter skinned fibers. Neither pCa50(the Ca++concentration for half-maximal tension) nor the slope of the tension-pCa relation was significantly different for halothane and control conditions. The control curve represents the mean of the initial and final control conditions.
Figure 4. Mean pCa-relative tension curves (where pCa=-log Ca++concentration) obtained in control conditions and with 0.75 vol% of halothane in nine type 1 masseter skinned fibers. Neither pCa50(the Ca++concentration for half-maximal tension) nor the slope of the tension-pCa relation was significantly different for halothane and control conditions. The control curve represents the mean of the initial and final control conditions.
×
Succinylcholine Sensitivity
The effect of succinylcholine on Ca++release from the SR was investigated in 22 masseter muscle fibers from five patients. Increasing concentrations of succinylcholine did not trigger Ca++release from SR of skinned fibers previously loaded with 0.16 [micro sign]M Ca++solution. The maximal concentration of 10 mM succinylcholine solution did not modify the halothane sensitivity.
Discussion
The main finding of our study is that halothane sensitivity was significantly higher in type 1 human masseter fibers compared with vastus lateralis fibers. This increase in halothane sensitivity results from a direct hypersensitivity of the SR. Because human masseter muscle is composed predominantly of large type 1 fibers, [14,16] although a range of distribution exists within fiber types, [11-15] our results may indicate the presence of a very low halothane reactivity threshold at this step (SR Ca (++) release) of the excitation-contraction coupling. This may explain, in part, the ability of the muscle to react to the combination of halothane and succinylcholine [3,24-27] with an increase in muscle tone leading to MMR in extreme cases. [3,4,26-28] 
Succinylcholine has no direct effect on SR or contractile proteins. Its action probably is mediated through activation of type 1 masseter fibers that elicited tonic contractions while the drug is present. [29] The resting tension of the masseter muscle increases in a dose-related manner as succinylcholine blocks neuromuscular function. [29] That study was performed in swine, and species differences may prevent this assumption of similar results in humans. Most clinical studies that assessed the effects of succinylcholine administration on jaw stiffness in children were done under halothane [3,24,26,28] or enflurane anesthesia. [4] Our results may explain, in part, why MMR is extremely rare after induction with thiopental followed by succinylcholine (no volatile anesthetic administered). [30] The presence of thiopental is believed to exert a protective effect, [31] and the report by Lazzell et al. [32] supports this concept. In a study by Christian et al., [2] the incidence of malignant hyperthermia susceptibility in children in whom MMR developed after an intravenous induction including succinylcholine was twice that in children with MMR after an inhalation induction and intravenous succinylcholine. This association suggests that the combination of halothane and succinylcholine yields a far greater incidence of MMR than that which can be accounted for by malignant hyperthermia susceptibility. Our findings provide further insight into the causes of the greater incidence of MMR; i.e., halothane increases the sensitivity of the SR Ca++release to succinylcholine-induced depolarization of the masseter muscle. In humans, halothane alone is insufficient to trigger MMR, and no reports exist in which halothane was not associated with succinylcholine.
Volatile anesthetics significantly affect several aspects of SR Ca (++) release channel activity. Halothane increases the rate of Ca++-inducedCa++release from isolated SR vesicles and reduces the luminal SR Ca++threshold at which Ca++-inducedCa++release occurs. [33] A stimulation of the rate constant for SR Ca++release by halothane is also observed with skinned fibers. [6,7] In both SR vesicles and skinned fibers, halothane increases the sensitivity of the SR Ca (++) release to activating Ca++. [8,9] A perplexing issue regarding the initiation of MMR is that halothane stimulates Ca++release from both masseter and vastus lateralis skinned fibers, whereas in vivo the addition of succinylcholine is required. The experimental system used, specifically the chemically skinned fibers, to examine the effects of volatile anesthetics on Ca++release channel function (ryanodine receptor) may have considerable influence on the results obtained. In several respects, the conditions of our experiments were different from those encountered in anesthetized persons. To preserve the viability of the skinned fiber preparations, it was necessary to work at temperatures less than 37 [degree sign]C. [8-10] This condition may considerably influence Ca++release. The Ca++adenosine triphosphatase of the SR and the opening of the ryanodine receptor probably are highly temperature sensitive. This may influence their behavior considerably. Finally, because minimum alveolar concentrations decrease with decreasing body temperature, our data may overestimate the effects of halothane on the SR and contractile apparatus.
Although the effects of volatile anesthetics on calcium sensitivity and the maximal force of contractile proteins have been evaluated extensively, few authors have compared the responsiveness of both type 1 and type 2 skeletal muscles using similar experimental conditions. Our results obtained with type 1 skinned masseter fibers are consistent with those reported by Ohta et al. [9] in saponin pretreatment of pig gracilis muscle. In their experiment, the pCa-tension relation of healthy muscle was not altered by halothane. [9] Similarly, Su et al. [34,35] found that halothane slightly decreased maximal Ca++-activatedtension in soleus muscle (type 1, slow twitch skeletal muscle), whereas halothane produced no change in the adductor magnus (type 2, fast twitch skeletal muscle).
We have no explanation for the difference in the effect of halothane on type 1 masseter compared with type 1 vastus lateralis muscle. A possible role of skeletal muscle-specific myofibril isoforms in the mechanism of halothane depression of contractility has been suggested. [10] Nevertheless, if these results can be extrapolated to in vivo conditions, they may partly explain the difference in the overall inotropic action of halothane between masseter and other muscles. Such significant negative inotropic effects on the maximal force of masseter contractile proteins may counteract the low halothane threshold reactivity of the SR. This may explain, in part, the inability of the masseter muscle to react to halothane alone without the presence of succinylcholine.
In conclusion, we found that halothane sensitivity of the SR was significantly greater in the masseter muscle compared with type 1 and type 2 vastus lateralis muscle. Such a significant effect could be counteracted by a direct negative inotropic effect on contractile apparatus. If these results can be extrapolated to in vivo conditions, they may explain why the combination of halothane and succinylcholine yields a far greater incidence of MMR than that which can be accounted for by malignant hyperthermia susceptibility.
REFERENCES
Fletcher JE, Rosenberg H: In vitro interaction between halothane and succinylcholine in human skeletal muscle: Implications for malignant hyperthermia and masseter rigidity. Anesthesiology 1985; 63:190-4
Christian AS, Ellis FR, Halsall PJ: Is there a relationship between masseteric muscle spasm and malignant hyperthermia? Br J Anaesth 1989; 62:540-4
Van der Spek AFL, Fang WB, Ashton-Miller J, Stobler CS, Carlson DS, Schork MM: The effect of syccinylcholine on mouth opening. Anesthesiology 1987; 67:459-65
Van der Speck AFL, Fang WB, Ashton-Miller J, Stabler CS, Carlson DS, Schork MA: Increased masticatory muscle stiffness during limb muscle flaciding associated with succinylcholine administration. Anesthesiology 1988; 69:11-6
Adnet PJ, Reyford H, Tavernier BM, Etchrivi T, Krivosic I, Krivosic-Horber R, Haudecoeur G: In vitro human masseter muscle hypersensitivity: A possible explanation for increase in masseter tone. J Appl Physiol 1996; 80:1547-53
Louis CF, Zualkernan K, Rochair T, Mickelson JR: The effects of volatile anesthetics on calcium regulation by malignant hyperthermia susceptible sarcoplasmic reticulum. Anesthesiology 1992; 77:114-25
Ohnishi ST, Waring AJ, Fang SR, Horurchi K, Flick JL, Sadanaga KK, Ohnishi T: Abnormal membrane properties of the sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia: Mode of action of halothane, caffeine, dantrolene and two other drugs. Arch Biochem Biophys 1986; 247:294-301
Endo H, yagi S, Ishizuka T, Horicki K, Kogo Y, Amaha K: Changes in the Ca+induced Ca release mechanism in the sarcoplasmic reticulum of the muscle from a patient with malignant hyperthermia. Biomed Res 1983; 4:83-92
Ohta T, Endo M, Nakano T, Morohosi Y, Wanikawa K, Ohga A: Ca (+) induced Ca release in malignant hyperthermia susceptible pig skeletal muscle. Am J Physiol 1989; 256:C358-67
Tavernier BM, Haddad E, Adnet PJ, Etchrivi TS, Lacroix D, Reyford H: Isoform-dependent effects of halothane in human skinned striated fibers. Anesthesiology 1996; 84:1138-47
Ringquist M: Fibre sizes of human masseter muscle in relation to bite force. J Neurol Sci 1973; 19:297-305
Serratrice GJ, Pellisier F, Vignon C, Baret J: The histochemical profile of the human masseter. An autopsy and biopsy study. J Neurol Sci 1976; 30:189-200
Vignon C, Pellissier JF, Serratrice G: Further histochemical studies on masticatory muscles. J Neurol Sci 1980; 45:157-76
Eriksson PO, Thornell LE: Histochemical and morphological muscle-fiber characteristics of the human masseter, the medial pterygoid and temporal muscles. Arch Oral Biol 1983; 28:781-95
Butler-Browne GS, Eriksson PO, Laurent C, Thornell LE: Adult human masseter muscle fibers express myosin isozymes characteristic of development. Muscle Nerve 1988; 11:610-20
Sciote JJ, Rowlerson AM, Hopper C, Hunt NP: Fiber-type classification and myosin isoforms in human masseter muscle. J Neurol Sci 1994; 126:15-24
Wood DS, Zollman J, Reuben JR; Brandt PW: Human skeletal muscle: Properties of the 'chemically skinned' fiber. Science 1975; 187:1075-6
Winegrad S: Studies of cardiac muscle with a high permeability to calcium producted by treatment with ethylenediaminetetra-acetic acid. J Gen Physiol 1971; 58:71-93
Takagi A, Yonemoto K, Sugita H: Single-skinned human muscle fibers: Activation by calcium and strontium. Neurology 1978; 28:497-9
Salviati G, Betto R, Ceoldo S, Tegazzin V, Della Puppa A: Caffeine sensitivity of sarcoplasmic reticulum of fast and slow fibers from normal and malignant hyperthermia human muscle. Muscle Nerve 1989; 12:365-70
Fink RHA, Stephenson DG, Williams DA: Physiological properties of skinned fibers from normal and dystrophic (Duchenne) human muscle activated by Ca++and Sr++. J Physiol 1990; 240:337-53
Holy X, Mounier Y: Effect of short spaceflights on mechanical characteristics of rat muscles. Muscle Nerve 1991; 14:70-8
Adnet PJ, Bromberg NL, Haudecoeur G, Krivosic I, Adamantidis M, Reyford H, Bello N, Krivosic-Horber R: Fiber type caffeine sensitivities in skinned muscle fibers from humans susceptible to malignant hyperthermia. Anesthesiology 1993; 78:168-77
Plamley MH, Bevan JC, Saddler JM, Donati F, Devan DR: Dose-related effects of succinylcholine on the adductor pollicis and masseter muscles in children. Can J Anaesth 1989; 37:15-20
Saddler JM, Bevan JC, Plumley MH, Polamens RC, Donadi F, Bevan DR: Jaw tension after succinylcholine in children undergoing strabismus surgery. Can J Anaesth 1989; 37:21-5
Carroll JB: Increased incidence of masseter spasm in children with strabismus anesthetized with halothane and succinylcholine. Anesthesiology 1987; 67:559-61
Leary NP, Ellis FR: Masseteric muscle spasm as a normal response to suxamethonium. Br J Anaesth 1990; 64:488-92
Schwartz L, Rockoff MA, Koka BV: Masseter spasm with anesthesia: Incidence and implications. Anesthesiology 1984; 61:772-5
Iaizzo PA, Wedel DJ: Response to succinylcholine in porcine malignant hyperthermia. Anesth Analg 1994; 79:143-51
Marohn ML, Nagia AH: Masster muscle rigidity after rapid-sequence induction of anesthesia. Anesthesiology 1992; 77:205-7
Gronert GA, Milde JH: Variations in onset of porcine malignant hyperthermia. Anesth Analg 1981; 60:400-3
Lazzell VA, Carr AS, Lermon J, Burrows FA, Greighton RE: The incidence of masseter muscle rigidity after succinylcholine in infants and children. Can J Anaesth 1994; 41:475-9
Nelson TE, Sweo T: Ca2+uptake and Ca2+release by skeletal muscle sarcoplasmic reticulum: Differing sensitivity to inhalational anesthetics. Anesthesiology 1988; 69:571-7
Su JY, Kerrick WGL: Effects of halothane on Ca++activated tension development in mechanically discrepted rabbit myocardial fibers. Pflugers Arch 1978; 375:111-7
Su JY, Bell JG: Intracellular mechanism of action of isoflurane and halothane on striated muscle of the rabbit. Anesth Analg 1986; 65:457-62
Figure 1. The sequence for determining halothane sensitivity in human skinned masseter muscle fibers. After the sarcoplasmic reticulum is loaded with Ca++solution (pCa 6.8; pCa =-log Ca++concentration), the fiber is exposed to a stepwise increase in halothane concentration. No contracture is obtained with 0.5 vol% halothane, but significant contracture (>10% increase in tension) is obtained with 1 vol% halothane (threshold contracture). Hal 0.5, 1, and Caf 40 are 0.5, 1 vol% halothane and 40 mM caffeine solutions, respectively.
Figure 1. The sequence for determining halothane sensitivity in human skinned masseter muscle fibers. After the sarcoplasmic reticulum is loaded with Ca++solution (pCa 6.8; pCa =-log Ca++concentration), the fiber is exposed to a stepwise increase in halothane concentration. No contracture is obtained with 0.5 vol% halothane, but significant contracture (>10% increase in tension) is obtained with 1 vol% halothane (threshold contracture). Hal 0.5, 1, and Caf 40 are 0.5, 1 vol% halothane and 40 mM caffeine solutions, respectively.
Figure 1. The sequence for determining halothane sensitivity in human skinned masseter muscle fibers. After the sarcoplasmic reticulum is loaded with Ca++solution (pCa 6.8; pCa =-log Ca++concentration), the fiber is exposed to a stepwise increase in halothane concentration. No contracture is obtained with 0.5 vol% halothane, but significant contracture (>10% increase in tension) is obtained with 1 vol% halothane (threshold contracture). Hal 0.5, 1, and Caf 40 are 0.5, 1 vol% halothane and 40 mM caffeine solutions, respectively.
×
Figure 2. Halothane sensitivities in human type 1 and 2 skinned masseter and vastus lateralis fibers. The halothane concentration that induced 10% of the maximal contracture with pCa 4.8 solution (pCa =-log Ca++concentration) is shown in panel A for each masseter muscle fiber (circle) and in panel B for each vastus lateralis fiber (square). Closed symbol = type 1 fiber; open symbol = type 2 fiber. There was a significant difference in halothane sensitivity (P < 0.001) between type 1 masseter muscle fiber (0.6 +/− 0.2 vol%) compared with type 1 or type 2 vastus lateralis fibers. There was no significant difference in halothane sensitivity between type 1 (2.7 +/− 0.6 vol%) and type 2 (2.5 +/− 0.4 vol%) vastus lateralis fibers.
Figure 2. Halothane sensitivities in human type 1 and 2 skinned masseter and vastus lateralis fibers. The halothane concentration that induced 10% of the maximal contracture with pCa 4.8 solution (pCa =-log Ca++concentration) is shown in panel A for each masseter muscle fiber (circle) and in panel B for each vastus lateralis fiber (square). Closed symbol = type 1 fiber; open symbol = type 2 fiber. There was a significant difference in halothane sensitivity (P < 0.001) between type 1 masseter muscle fiber (0.6 +/− 0.2 vol%) compared with type 1 or type 2 vastus lateralis fibers. There was no significant difference in halothane sensitivity between type 1 (2.7 +/− 0.6 vol%) and type 2 (2.5 +/− 0.4 vol%) vastus lateralis fibers.
Figure 2. Halothane sensitivities in human type 1 and 2 skinned masseter and vastus lateralis fibers. The halothane concentration that induced 10% of the maximal contracture with pCa 4.8 solution (pCa =-log Ca++concentration) is shown in panel A for each masseter muscle fiber (circle) and in panel B for each vastus lateralis fiber (square). Closed symbol = type 1 fiber; open symbol = type 2 fiber. There was a significant difference in halothane sensitivity (P < 0.001) between type 1 masseter muscle fiber (0.6 +/− 0.2 vol%) compared with type 1 or type 2 vastus lateralis fibers. There was no significant difference in halothane sensitivity between type 1 (2.7 +/− 0.6 vol%) and type 2 (2.5 +/− 0.4 vol%) vastus lateralis fibers.
×
Figure 3. An example of the changes in maximal activated tension obtained in a skinned masseter muscle fiber during exposure to 0.75 vol% halothane at pCa 4.8 (pCa =-log Ca++concentration). Each exposure to halothane was preceded and followed by determination with the pCa 4.8 control solution alone. Hal 0.75% and R are halothane 0.75 vol% and relaxing solutions, respectively.
Figure 3. An example of the changes in maximal activated tension obtained in a skinned masseter muscle fiber during exposure to 0.75 vol% halothane at pCa 4.8 (pCa =-log Ca++concentration). Each exposure to halothane was preceded and followed by determination with the pCa 4.8 control solution alone. Hal 0.75% and R are halothane 0.75 vol% and relaxing solutions, respectively.
Figure 3. An example of the changes in maximal activated tension obtained in a skinned masseter muscle fiber during exposure to 0.75 vol% halothane at pCa 4.8 (pCa =-log Ca++concentration). Each exposure to halothane was preceded and followed by determination with the pCa 4.8 control solution alone. Hal 0.75% and R are halothane 0.75 vol% and relaxing solutions, respectively.
×
Figure 4. Mean pCa-relative tension curves (where pCa=-log Ca++concentration) obtained in control conditions and with 0.75 vol% of halothane in nine type 1 masseter skinned fibers. Neither pCa50(the Ca++concentration for half-maximal tension) nor the slope of the tension-pCa relation was significantly different for halothane and control conditions. The control curve represents the mean of the initial and final control conditions.
Figure 4. Mean pCa-relative tension curves (where pCa=-log Ca++concentration) obtained in control conditions and with 0.75 vol% of halothane in nine type 1 masseter skinned fibers. Neither pCa50(the Ca++concentration for half-maximal tension) nor the slope of the tension-pCa relation was significantly different for halothane and control conditions. The control curve represents the mean of the initial and final control conditions.
Figure 4. Mean pCa-relative tension curves (where pCa=-log Ca++concentration) obtained in control conditions and with 0.75 vol% of halothane in nine type 1 masseter skinned fibers. Neither pCa50(the Ca++concentration for half-maximal tension) nor the slope of the tension-pCa relation was significantly different for halothane and control conditions. The control curve represents the mean of the initial and final control conditions.
×